title: Atenolol treatment for infantile haemangioma.
authors.affiliation: Great Ormond Street Hospital, NHS Foundation Trust, London, WC1N 3JH, U.K.
authors.forename: M
authors.identifier: 0000-0002-8139-3058
authors.initials: M
authors.lastname: Tasani
authors.affiliation: Great Ormond Street Hospital, NHS Foundation Trust, London, WC1N 3JH, U.K.
authors.forename: M
authors.initials: M
authors.lastname: Glover
authors.affiliation: Great Ormond Street Hospital, NHS Foundation Trust, London, WC1N 3JH, U.K.
authors.forename: A E
authors.initials: AE
authors.lastname: Martinez
authors.affiliation: Great Ormond Street Hospital, NHS Foundation Trust, London, WC1N 3JH, U.K.
authors.forename: L
authors.initials: L
authors.lastname: Shaw
mesh_terms: D000284:Administration, Oral; D058671:Adrenergic beta-1 Receptor Antagonists / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001262:Atenolol / Q000008:administration & dosage*; D005260:Female; D006391:Hemangioma / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D008297:Male; D012878:Skin Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D058671:Adrenergic beta-1 Receptor Antagonists; D000970:Antineoplastic Agents; D001262:Atenolol